Synergistic Effect of Curcumin and Cisplatin via Down-Regulation of Thymidine Phosphorylase and Excision Repair Cross-Complementary 1 (ERCC1)

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Molecular Pharmacology

• Publication date

  2011-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/mol.111.071316PMID 21493726
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2.

  2010cited by this paper
• Regulation of Excision Repair Cross-Complementation Group 1 by Snail Contributes to Cisplatin Resistance in Head and Neck Cancer

  2010cited by this paper
• Heme Oxygenase-1 Inhibits the Proliferation of Pancreatic Stellate Cells by Repression of the Extracellular Signal-Regulated Kinase1/2 Pathway

  2008cited by this paper
• Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP‐1 and NFκB transcription factors

  2007influential reference
• Curcumin induces G2/M arrest and apoptosis in cisplatin-resistant human ovarian cancer cells by modulating akt and p38 mAPK

  2007influential reference
• Excision repair cross‐complementation group 1 predicts progression‐free and overall survival in non‐small cell lung cancer patients treated with platinum‐based chemotherapy

  2007cited by this paper
• Curcumin Augments Gemcitabine Cytotoxic Effect on Pancreatic Adenocarcinoma Cell Lines

  2007cited by this paper
• Protection against DNA damage‐induced apoptosis by the angiogenic factor thymidine phosphorylase

  2006cited by this paper
• Cancer Statistics, 2006

  2006cited by this paper
• Curcumin (Diferuloylmethane) Down-Regulates Expression of Cell Proliferation and Antiapoptotic and Metastatic Gene Products through Suppression of IκBα Kinase and Akt Activation

  2006cited by this paper
• Curcumin suppresses constitutive activation of AP-1 by downregulation of JunD protein in HTLV-1-infected T-cell lines.

  2006influential reference
• Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway

  2006cited by this paper
• Chemoresistance in non-small cell lung cancer.

  2005cited by this paper
• Sensitization of Taxol-induced Apoptosis by Curcumin Involves Down-regulation of Nuclear Factor-κB and the Serine/Threonine Kinase Akt and Is Independent of Tubulin Polymerization*

  2005cited by this paper
• Curcumin Suppresses the Paclitaxel-Induced Nuclear Factor-κB Pathway in Breast Cancer Cells and Inhibits Lung Metastasis of Human Breast Cancer in Nude Mice

  2005cited by this paper
• Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5).

  2005cited by this paper
• Curcumin: Getting Back to the Roots

  2005cited by this paper
• Activation of ERK during DNA damage-induced apoptosis involves protein kinase Cdelta.

  2005cited by this paper
• Thymidine phosphorylase suppresses apoptosis induced by microtubule-interfering agents.

  2005cited by this paper
• Mechanisms of platinum drug resistance.

  2005cited by this paper
• Synergistic Inhibitory Effects of Curcumin and 5-Fluorouracil on the Growth of the Human Colon Cancer Cell Line HT-29

  2005cited by this paper
• The Structure-Specific Endonuclease Ercc1-Xpf Is Required To Resolve DNA Interstrand Cross-Link-Induced Double-Strand Breaks

  2004cited by this paper
• Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation.

  2004cited by this paper
• Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-KB through suppression of IKBA phosphorylation

  2004cited by this paper
• Induction of apoptosis in human lung cancer cells by curcumin.

  2004cited by this paper
• Excision repair cross complementing-group 1: gene expression and platinum resistance.

  2004cited by this paper
• Cisplatin: mode of cytotoxic action and molecular basis of resistance

  2003cited by this paper
• Thymidine phosphorylase inhibits apoptosis induced by cisplatin.

  2003cited by this paper
• Molecular mechanisms of curcumin-induced cytotoxicity: induction of apoptosis through generation of reactive oxygen species, down-regulation of Bcl-XL and IAP, the release of cytochrome c and inhibition of Akt.

  2003influential reference
• Inhibition of glutathione synthesis reverses Bcl-2-mediated cisplatin resistance.

  2003cited by this paper
• DNA repair and cisplatin resistance in non-small-cell lung cancer.

  2002cited by this paper
• Transcription-coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cells.

  2002cited by this paper
• Curcumin suppresses activation of NF-kappaB and AP-1 induced by phorbol ester in cultured human promyelocytic leukemia cells.

  2002cited by this paper
• Thymidine phosphorylase suppresses Fas-induced apoptotic signal transduction independent of its enzymatic activity.

  2002cited by this paper
• Ras-mediated activation of ERK by cisplatin induces cell death independently of p53 in osteosarcoma and neuroblastoma cell lines

  2002cited by this paper
• Therapeutic potential of curcumin in human prostate cancer. III. Curcumin inhibits proliferation, induces apoptosis, and inhibits angiogenesis of LNCaP prostate cancer cells in vivo

  2001cited by this paper
• Expression levels of thymidine phosphorylase and dihydropyrimidine dehydrogenase in various human tumor tissues.

  2000cited by this paper
• Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by curcumin

  1998cited by this paper
• Cisplatin Induction of ERCC-1 mRNA Expression in A2780/CP70 Human Ovarian Cancer Cells*

  1998cited by this paper
• Cancer statistics

  1989cited by this paper

• Curcumin-like Compound Inhibits Proliferation of Adenocarcinoma Cells by Inducing Cell Cycle Arrest and Senescence

  2025cites this paper
• The role of polyphenols in overcoming cancer drug resistance: a comprehensive review

  2022cites this paper
• Curcumin and Its Analogs in Non-Small Cell Lung Cancer Treatment: Challenges and Expectations

  2022cites this paper
• Curcumin–cisplatin chemotherapy: A novel strategy in promoting chemotherapy efficacy and reducing side effects

  2021cites this paper
• Reversal of cisplatin resistance by neferine/isoliensinine and their combinatorial regimens with cisplatin‐induced apoptosis in cisplatin‐resistant colon cancer stem cells (CSCs)

  2021cites this paper
• Curcumin and its derivatives in cancer therapy: Potentiating antitumor activity of cisplatin and reducing side effects

  2021cites this paper
• A New Perspective on Cancer Therapy: Changing the Treaded Path?

  2021cites this paper
• Demethoxycurcumin increases the sensitivity of cisplatin-resistant non-small lung cancer cells to cisplatin and induces apoptosis by activating the caspase signaling pathway

  2020cites this paper
• Phytochemicals in cancer cell chemosensitization: Current knowledge and future perspectives.

  2020cites this paper
• Therapeutic potentials of curcumin in the treatment of non‐small‐cell lung carcinoma

  2020cites this paper
• Intercalation of curcumin into liposomal chemotherapeutic agent augments apoptosis in breast cancer cells

  2020influential citation
• Natural Compounds That Target DNA Repair Pathways and Their Therapeutic Potential to Counteract Cancer Cells

  2020cites this paper
• Combinations of the antioxidants sulforaphane or curcumin and the conventional antineoplastics cisplatin or doxorubicin as prospects for anticancer chemotherapy.

  2019cites this paper
• Association Study Among Candidate Genetic Polymorphisms and Chemotherapy-Related Severe Toxicity in Testicular Cancer Patients

  2019cites this paper
• Demethoxycurcumin sensitizes the response of non-small cell lung cancer to cisplatin through downregulation of TP and ERCC1-related pathways.

  2019cites this paper
• Demethoxycurcumin-Loaded Chitosan Nanoparticle Downregulates DNA Repair Pathway to Improve Cisplatin-Induced Apoptosis in Non-Small Cell Lung Cancer

  2018cites this paper
• The Potential of Curcumin: A Multitargeting Agent in Cancer Cell Chemosensitization

  2018cites this paper
• Cinnamaldehyde enhances cytotoxic effect of cisplatin by ROS-induced autophagy in cisplatin-resistant ovarian cancer cells.

  2017cites this paper
• Molecular mechanisms underlying chemopreventive potential of curcumin: Current challenges and future perspectives.

  2016cites this paper
• Curcumin downregulates p38 MAPK-dependent X-ray repair cross-complement group 1 (XRCC1) expression to enhance cisplatin-induced cytotoxicity in human lung cancer cells

  2016cites this paper
• Multi-Targeted Agents in Cancer Cell Chemosensitization: What We Learnt from Curcumin Thus Far.

  2016cites this paper
• Co-administration of cisplatin and curcumin does not alter mood-associated behaviors.

  2016cites this paper
• The final checkpoint. Cancer as an adaptive evolutionary mechanism

  2016cites this paper
• Dimethyl sulfoxide inactivates the anticancer effect of cisplatin against human myelogenous leukemia cell lines in in vitro assays

  2015cites this paper
• Curcumin Triggers DNA Damage and Inhibits Expression of DNA Repair Proteins in Human Lung Cancer Cells.

  2015cites this paper
• Antiproliferative effects of curcumin analog L49H37 in pancreatic stellate cells: a comparative study

  2015cites this paper
• Mixed copper-platinum complex formation could explain synergistic antiproliferative effect exhibited by binary mixtures of cisplatin and copper-1,10-phenanthroline compounds: An ESI-MS study.

  2015cites this paper
• Regulation and Novel Action of Thymidine Phosphorylase in Non-Small Cell Lung Cancer: Crosstalk with Nrf2 and HO-1

  2014cites this paper
• What's your poison? Impact of individual repair capacity on the outcomes of genotoxic therapies in cancer. Part II – information content and validity of biomarkers for individual repair capacity in the assessment of outcomes of anticancer therapy

  2014cites this paper
• Effect of Uncaria tomentosa Extract on Apoptosis Triggered by Oxaliplatin Exposure on HT29 Cells

  2014cites this paper
• O açafrão das Índias e as suas propriedades antitumorais

  2014cites this paper
• Therapeutic applications of curcumin for patients with pancreatic cancer.

  2014cites this paper
• Curcumin induces apoptosis and inhibits growth of orthotopic human non-small cell lung cancer xenografts.

  2014cites this paper
• Curcumin as a cancer chemotherapy sensitizing agent

  2014cites this paper
• Curcumin and lung cancer—a review

  2014cites this paper
• Synergistic interaction of paclitaxel and curcumin with cyclodextrin polymer complexation in human cancer cells.

  2013cites this paper
• Customizing chemotherapy in thoracic malignancies based on ERCC1 expression

  2013cites this paper
• The influence of curcumin on the action of etoposide in a rat acute myeloid leukemia cell line.

  2013cites this paper
• Attenuation of Multifocal Cell Survival Signaling by Bioactive Phytochemicals in the Prevention and Therapy of Cancer

  2013cites this paper
• Antiproliferative effect of hydroethanolic extracts of seeds of Cola verticillata and leaves of Solanum scabrum

  2013cites this paper
• Cellular, Molecular, and Biological Perspective of Polyphenols in Chemoprevention and Therapeutic Adjunct in Cancer 71

  2013cites this paper
• Fucoxanthin Enhances Cisplatin-Induced Cytotoxicity via NFκB-Mediated Pathway and Downregulates DNA Repair Gene Expression in Human Hepatoma HepG2 Cells

  2013cites this paper
• Toxic effects induced by curcumin in human astrocytoma cell lines

  2013cites this paper
• Pemetrexed downregulates ERCC1 expression and enhances cytotoxicity effected by resveratrol in human nonsmall cell lung cancer cells

  2013cites this paper
• Augmenting the Efficacy of Chemo- and Radio-Therapy by Nutraceuticals: Evidence from Pre-clinical and Clinical Trials

  2012cites this paper
• 12 The Potential Role of Curcumin for Treatment of Pancreatic Cancer

  2012cites this paper
• The Potential Role of Curcumin for Treatment of Pancreatic Cancer

  2012cites this paper
• Emodin affects ERCC1 expression in breast cancer cells

  2012cites this paper
• Curcumin enhances the mitomycin C-induced cytotoxicity via downregulation of MKK1/2-ERK1/2-mediated Rad51 expression in non-small cell lung cancer cells.

  2011cites this paper
• Dietary phytochemicals, HDAC inhibition, and DNA damage/repair defects in cancer cells

  2011cites this paper